These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 36991274

  • 1. Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas.
    Nishikawa T, Ohka F, Aoki K, Suzuki H, Motomura K, Yamaguchi J, Maeda S, Kibe Y, Shimizu H, Natsume A, Innan H, Saito R.
    Brain Tumor Pathol; 2023 Apr; 40(2):85-92. PubMed ID: 36991274
    [Abstract] [Full Text] [Related]

  • 2. MRI Scoring Systems for Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q Codeletion in Adult-type Diffuse Glioma Lacking Contrast Enhancement.
    Kang KM, Song J, Choi Y, Park C, Park JE, Kim HS, Park SH, Park CK, Choi SH.
    Radiology; 2024 May; 311(2):e233120. PubMed ID: 38713025
    [Abstract] [Full Text] [Related]

  • 3. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
    Goyal A, Yolcu YU, Goyal A, Kerezoudis P, Brown DA, Graffeo CS, Goncalves S, Burns TC, Parney IF.
    Neurosurg Focus; 2019 Dec 01; 47(6):E13. PubMed ID: 31786548
    [Abstract] [Full Text] [Related]

  • 4. MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization.
    Patel SH, Batchala PP, Mrachek EKS, Lopes MS, Schiff D, Fadul CE, Patrie JT, Jain R, Druzgal TJ, Williams ES.
    Radiology; 2020 Jan 01; 294(1):160-167. PubMed ID: 31714193
    [No Abstract] [Full Text] [Related]

  • 5. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.
    Yang X, Lin Y, Xing Z, She D, Su Y, Cao D.
    Acta Radiol; 2021 Dec 01; 62(12):1657-1665. PubMed ID: 33222488
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
    Zhou H, Chang K, Bai HX, Xiao B, Su C, Bi WL, Zhang PJ, Senders JT, Vallières M, Kavouridis VK, Boaro A, Arnaout O, Yang L, Huang RY.
    J Neurooncol; 2019 Apr 01; 142(2):299-307. PubMed ID: 30661193
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas.
    Park YW, Han K, Ahn SS, Bae S, Choi YS, Chang JH, Kim SH, Kang SG, Lee SK.
    AJNR Am J Neuroradiol; 2018 Jan 01; 39(1):37-42. PubMed ID: 29122763
    [Abstract] [Full Text] [Related]

  • 11. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas.
    Yamauchi T, Ohno M, Matsushita Y, Takahashi M, Miyakita Y, Kitagawa Y, Kondo E, Tsushita N, Satomi K, Yoshida A, Ichimura K, Narita Y.
    Brain Tumor Pathol; 2018 Jul 01; 35(3):148-158. PubMed ID: 29922974
    [Abstract] [Full Text] [Related]

  • 12. Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in IDH-Mutant Lower Grade Gliomas.
    Batchala PP, Muttikkal TJE, Donahue JH, Patrie JT, Schiff D, Fadul CE, Mrachek EK, Lopes MB, Jain R, Patel SH.
    AJNR Am J Neuroradiol; 2019 Mar 01; 40(3):426-432. PubMed ID: 30705071
    [Abstract] [Full Text] [Related]

  • 13. Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q Deletion.
    Lasocki A, Buckland ME, Molinaro T, Xie J, Gaillard F.
    AJNR Am J Neuroradiol; 2023 Nov 01; 44(11):1270-1274. PubMed ID: 37884300
    [Abstract] [Full Text] [Related]

  • 14. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
    Lee MK, Park JE, Jo Y, Park SY, Kim SJ, Kim HS.
    Eur Radiol; 2020 Feb 01; 30(2):844-854. PubMed ID: 31446467
    [Abstract] [Full Text] [Related]

  • 15. The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.
    Zhao K, Sun G, Wang Q, Xue Z, Liu G, Xia Y, Yao A, Zhao Y, You N, Yang C, Xu B.
    Acad Radiol; 2021 Jul 01; 28(7):e189-e198. PubMed ID: 32359929
    [Abstract] [Full Text] [Related]

  • 16. HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.
    Felix M, Friedel D, Jayavelu AK, Filipski K, Reinhardt A, Warnken U, Stichel D, Schrimpf D, Korshunov A, Wang Y, Kessler T, Etminan N, Unterberg A, Herold-Mende C, Heikaus L, Sahm F, Wick W, Harter PN, von Deimling A, Reuss DE.
    Neuro Oncol; 2022 Dec 01; 24(12):2121-2132. PubMed ID: 35511748
    [Abstract] [Full Text] [Related]

  • 17. Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study.
    Habiba U, Sugino H, Yordanova R, Ise K, Tanei ZI, Ishida Y, Tanikawa S, Terasaka S, Sato KI, Kamoshima Y, Katoh M, Nagane M, Shibahara J, Tsuda M, Tanaka S.
    Acta Neuropathol Commun; 2021 May 21; 9(1):95. PubMed ID: 34020723
    [Abstract] [Full Text] [Related]

  • 18. Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of IDH1-Mutation and 1p/19q-Codeletion Status in World Health Organization Grade II Gliomas.
    Park YW, Han K, Ahn SS, Choi YS, Chang JH, Kim SH, Kang SG, Kim EH, Lee SK.
    AJNR Am J Neuroradiol; 2018 Apr 21; 39(4):693-698. PubMed ID: 29519794
    [Abstract] [Full Text] [Related]

  • 19. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
    Zhu Z, Lan Y, Wang L, Ge J, Wang J, Liu F, He Z, Zhang H, Luo M, Lin D, Tan Y, Xu Y, Luo T.
    BMC Cancer; 2020 Nov 09; 20(1):1072. PubMed ID: 33167941
    [Abstract] [Full Text] [Related]

  • 20. High-grade gliomas with isocitrate dehydrogenase wild-type and 1p/19q codeleted: Atypical molecular phenotype and current challenges in molecular diagnosis.
    Zheng L, Zhang M, Hou J, Gong J, Nie L, Chen X, Zhou Q, Chen N.
    Neuropathology; 2020 Dec 09; 40(6):599-605. PubMed ID: 32761642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.